| Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial M de Sio, R Autorino, G Quarto, R Damiano, S Perdonà, G di Lorenzo, ... Urology 67 (1), 69-72, 2006 | 210 | 2006 |
| Robotic versus laparoscopic adrenalectomy: a systematic review and meta-analysis LF Brandao, R Autorino, H Laydner, GP Haber, I Ouzaid, M De Sio, ... European Urology 65 (6), 1154-1161, 2014 | 209 | 2014 |
| Gemcitabine versus bacille Calmette‐Guerin after initial bacille Calmette‐Guerin failure in non‐muscle‐invasive bladder cancer: a multicenter prospective randomized trial G Di Lorenzo, S Perdonà, R Damiano, A Faiella, F Cantiello, S Pignata, ... Cancer 116 (8), 1893-1900, 2010 | 192 | 2010 |
| Epithelial-mesenchymal transition in prostate cancer: an overview M Montanari, S Rossetti, C Cavaliere, C D'Aniello, MG Malzone, ... Oncotarget 8 (21), 35376, 2017 | 188 | 2017 |
| Microbiota effects on cancer: from risks to therapies D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete, ... Oncotarget 9 (25), 17915, 2018 | 184 | 2018 |
| Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study G Di Lorenzo, WD Figg, SD Fossa, V Mirone, R Autorino, N Longo, ... European urology 54 (5), 1089-1096, 2008 | 175 | 2008 |
| The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand? R Autorino, M De Sio, R Damiano, G Di Lorenzo, S Perdonà, A Russo, ... Urological research 33, 460-464, 2005 | 172 | 2005 |
| Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer G Di Lorenzo, G Cartenì, R Autorino, G Bruni, M Tudini, M Rizzo, M Aieta, ... Journal of Clinical Oncology 27 (27), 4469-4474, 2009 | 168 | 2009 |
| Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study R Damiano, R Autorino, M De Sio, F Cantiello, G Quarto, S Perdonà, ... European urology 48 (4), 673-678, 2005 | 150 | 2005 |
| Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate R Autorino, R Damiano, G Di Lorenzo, G Quarto, S Perdonà, ... European urology 55 (4), 922-931, 2009 | 149 | 2009 |
| Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study M D'armiento, R Damiano, B Feleppa, S Perdona, G Oriani, M De Sio British journal of urology 79 (1), 15-19, 1997 | 149 | 1997 |
| Micrornas in prostate cancer: an overview D Vanacore, M Boccellino, S Rossetti, C Cavaliere, C D'Aniello, ... Oncotarget 8 (30), 50240, 2017 | 138 | 2017 |
| How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature R Autorino, M De Sio, G Di Lorenzo, R Damiano, S PerdonÀ, L Cindolo, ... The Journal of urology 174 (6), 2091-2097, 2005 | 137 | 2005 |
| Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis R Damiano, G Di Lorenzo, F Cantiello, M De Sio, S Perdonà, ... European urology 52 (3), 648-657, 2007 | 134 | 2007 |
| Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2–10 ng/ml M Ferro, D Bruzzese, S Perdona, A Marino, C Mazzarella, G Perruolo, ... PloS one 8 (7), e67687, 2013 | 129 | 2013 |
| Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial S Perdonà, R Autorino, S De Placido, M D'Armiento, A Gallo, R Damiano, ... The lancet oncology 6 (5), 295-300, 2005 | 123 | 2005 |
| Bladder‐sparing, combined‐modality approach for muscle‐invasive bladder cancer: a multi‐institutional, long‐term experience S Perdonà, R Autorino, R Damiano, M De Sio, B Morrica, L Gallo, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 118 | 2008 |
| Outcomes of robot-assisted partial nephrectomy for clinical T2 renal tumors: a multicenter analysis (ROSULA Collaborative Group) R Bertolo, R Autorino, G Simone, I Derweesh, JD Garisto, A Minervini, ... European urology 74 (2), 226-232, 2018 | 117 | 2018 |
| Prostate cancer detection in the “grey area” of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun’s nomogram, two risk … S Perdona, V Cavadas, G Di Lorenzo, R Damiano, G Chiappetta, ... European urology 59 (1), 81-87, 2011 | 109 | 2011 |
| Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer C D'alterio, C Consales, M Polimeno, R Franco, L Cindolo, L Portella, ... Current cancer drug targets 10 (7), 772-781, 2010 | 107 | 2010 |
